Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionPrincipal Financial Group Inc
Latest Disclosed Ownership1,769,886 shares
Latest Disclosed Value $ 246,669,013
Principal Financial Group Inc reports 0.45% increase in ownership of GILD / Gilead Sciences, Inc.

On May 4, 2026 - Principal Financial Group Inc filed a 13F-HR form disclosing ownership of 1,769,886 shares of Gilead Sciences, Inc. (CH:GILD) valued at $246,669,013 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 1,762,006 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.45% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F GILEAD SCIENCES COM 375558103 1,769,886 7,880 0.45 246,669 14.06 0.1317
2026-02-02 2025-12-31 13F GILEAD SCIENCES COM 375558103 1,762,006 379,592 27.46 216,269 40.94 0.1104
2025-11-04 2025-09-30 13F GILEAD SCIENCES COM 375558103 1,382,414 -18,461 -1.32 153,448 -1.20 0.0774
2025-08-08 2025-06-30 13F GILEAD SCIENCES COM 375558103 1,400,875 -45,511 -3.15 155,315 -4.17 0.0821
2025-04-28 2025-03-31 13F GILEAD SCIENCES COM 375558103 1,446,386 -8,272 -0.57 162,068 20.62 0.0909
2025-01-31 2024-12-31 13F GILEAD SCIENCES COM 375558103 1,454,658 3,409 0.23 134,367 10.43 0.0733
2024-10-31 2024-09-30 13F GILEAD SCIENCES COM 375558103 1,451,249 59,181 4.25 121,673 27.39 0.0670
2024-07-29 2024-06-30 13F GILEAD SCIENCES COM 375558103 1,392,068 -61,828 -4.25 95,510 -10.32 0.0567
2024-04-29 2024-03-31 13F GILEAD SCIENCES COM 375558103 1,453,896 -5,656 -0.39 106,498 -9.93 0.0626
2024-02-07 2023-12-31 13F GILEAD SCIENCES COM 375558103 1,459,552 -219,421 -13.07 118,238 -6.03 0.0754
2023-11-02 2023-09-30 13F GILEAD SCIENCES COM 375558103 1,678,973 107,844 6.86 125,822 3.91 0.0904
2023-08-07 2023-06-30 13F GILEAD SCIENCES COM 375558103 1,571,129 40,682 2.66 121,087 -4.64 0.0828
2023-05-09 2023-03-31 13F GILEAD SCIENCES COM 375558103 1,530,447 14,092 0.93 126,981 -2.46 0.0908
2023-02-09 2022-12-31 13F GILEAD SCIENCES COM 375558103 1,516,355 -35,631 -2.30 130,179 35.97 0.0980
2022-11-09 2022-09-30 13F GILEAD SCIENCES COM 375558103 1,551,986 59,861 4.01 95,742 3.81 0.0761
2022-08-10 2022-06-30 13F GILEAD SCIENCES COM 375558103 1,492,125 -22,809 -1.51 92,228 2.41 0.0682
2022-05-09 2022-03-31 13F GILEAD SCIENCES COM 375558103 1,514,934 40,869 2.77 90,062 -15.86 0.0357
2022-05-09 2022-03-31 13F GILEAD SCIENCES COM 375558103 1,481,032 88,047
2022-02-09 2021-12-31 13F GILEAD SCIENCES COM 375558103 1,474,065 -33,814 -2.24 107,032 1.62 0.0639
2021-11-09 2021-09-30 13F GILEAD SCIENCES COM 375558103 1,507,879 -7,564 -0.50 105,325 0.93 0.0687
2021-08-10 2021-06-30 13F GILEAD SCIENCES COM 375558103 1,515,443 21,687 1.45 104,353 8.09 0.0674
2021-05-10 2021-03-31 13F GILEAD SCIENCES COM 375558103 1,493,756 -121,635 -7.53 96,542 2.58 0.0681
2021-02-23 2020-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 1,615,391 -95,689 -5.59 94,113 -12.96 0.0697
2021-02-08 2020-12-31 13F GILEAD SCIENCES COM 375558103 1,615,391 -95,689 94,113 37,025.5046
2020-11-06 2020-09-30 13F GILEAD SCIENCES COM 375558103 1,711,080 -92,092 -5.11 108,123 -22.07 0.0910
2020-08-05 2020-06-30 13F GILEAD SCIENCES COM 375558103 1,803,172 37,505 2.12 138,736 5.10 0.1230
2020-05-12 2020-03-31 13F GILEAD SCIENCES COM 375558103 1,765,667 12,068 0.69 132,001 15.84 0.1461
2020-02-05 2019-12-31 13F GILEAD SCIENCES COM 375558103 1,753,599 -56,206 -3.11 113,949 -0.66 0.0949
2019-11-13 2019-09-30 13F GILEAD SCIENCES COM 375558103 1,809,805 -7,825 -0.43 114,705 -6.59 0.1011
2019-08-12 2019-06-30 13F GILEAD SCIENCES COM 375558103 1,817,630 -47,716 -2.56 122,799 1.26 0.1104
2019-05-10 2019-03-31 13F GILEAD SCIENCES COM 375558103 1,865,346 -171,449 -8.42 121,266 -4.82 0.1130
2019-02-14 2018-12-31 13F GILEAD SCIENCES COM 375558103 2,036,795 -122,389 -5.67 127,401 -23.58 0.1358
2018-11-14 2018-09-30 13F GILEAD SCIENCES COM 375558103 2,159,184 7,548 0.35 166,711 9.37 0.1469
2018-08-13 2018-06-30 13F GILEAD SCIENCES COM 375558103 2,151,636 -793,959 -26.95 152,422 -31.36 0.1401
2018-05-14 2018-03-31 13F GILEAD SCIENCES COM 375558103 2,945,595 148,398 5.31 222,068 10.82 0.2134
2018-02-12 2017-12-31 13F GILEAD SCIENCES COM 375558103 2,797,197 -447,189 -13.78 200,392 -23.76 0.1845
2017-11-02 2017-09-30 13F GILEAD SCIENCES COM 375558103 3,244,386 -664,719 -17.00 262,860 -5.00 0.2549
2017-08-08 2017-06-30 13F GILEAD SCIENCES COM 375558103 3,909,105 1,140,112 41.17 276,687 47.12 0.2773
2017-05-11 2017-03-31 13F GILEAD SCIENCES COM 375558103 2,768,993 -623,067 -18.37 188,070 -22.57 0.2263
2017-02-13 2016-12-31 13F GILEAD SCIENCES COM 375558103 3,392,060 90,531 2.74 242,905 -7.01 0.3081
2016-11-10 2016-09-30 13F GILEAD SCIENCES COM 375558103 3,301,529 151,455 4.81 261,217 -0.59 0.3450
2016-08-09 2016-06-30 13F GILEAD SCIENCES COM 375558103 3,150,074 -371,880 -10.56 262,779 -18.78 0.3666
2016-05-10 2016-03-31 13F GILEAD SCIENCES COM 375558103 3,521,954 515,481 17.15 323,527 6.34 0.4697
2016-02-09 2015-12-31 13F GILEAD SCIENCES COM 375558103 3,006,473 -221,331 -6.86 304,225 -4.01 0.4520
2015-11-12 2015-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 3,227,804 251,293 8.44 316,938 -9.05 0.4980
2015-11-09 2015-09-30 13F GILEAD SCIENCES COM 375558103 3,227,804 316,938
2015-08-10 2015-06-30 13F GILEAD SCIENCES COM 375558103 2,976,511 370,309 14.21 348,490 36.26 0.5197
2015-05-14 2015-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 2,606,202 -416,080 -13.77 255,747 -10.23 0.3810
2015-05-12 2015-03-31 13F GILEAD SCIENCES COM 375558103 2,606,202 255,747
2015-02-12 2014-12-31 13F GILEAD SCIENCES COM 375558103 3,022,282 191,409 6.76 284,880 -5.46 0.4426
2014-11-13 2014-09-30 13F GILEAD SCIENCES COM 375558103 2,830,873 152,146 5.68 301,347 35.68 0.5113
2014-08-12 2014-06-30 13F GILEAD SCIENCES COM 375558103 2,678,727 -671,405 -20.04 222,094 -6.44 0.3735
2014-05-13 2014-03-31 13F GILEAD SCIENCES COM 375558103 3,350,132 6,869 0.21 237,391 -5.51 0.4235
2014-02-12 2013-12-31 13F GILEAD SCIENCES COM 375558103 3,343,263 32,946 1.00 251,244 20.78 0.4689
2013-11-05 2013-09-30 13F GILEAD SCIENCES COM 375558103 3,310,317 760,018 29.80 208,021 59.28 0.4297
2013-08-12 2013-06-30 13F GILEAD SCIENCES COM 375558103 2,550,299 2,550,299 130,604 0.2893
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.